Naltrexone implant in opioid addiction practice
Naltrexone implant has huge perspective in assisting to avoid a reversion in heroin addiction. An enduring invention for naltrexone injections is anticipated to supplementary diminish non-adherence and deterioration throughout the treatment process of opiate addiction.
Naltrexone implant “Subiaco” – Clinical Study
The aim of this study is to assess the danger (if any) and helpfulness of 24-weeks anti-opiates naltrexone implantation in plummeting of opioids consumption after rehabilitation in a specialized facility.
A group of 65 heroine-addicted individuals who finished in-patient rehabilitation for opioid addiction was unsystematically and willingly allocated to be given either a 24-weeks anti-opioid implant or traditional medical care. Opioids consumption and other results were considered at 24-weeks follow-up visit.
Results documented from use of naltrexone implants
Individuals that got implant treatment had on average 7.5 weeks less heroin consumption than the controlled group in the 6-months period. Blood work revealed the naltrexone concentration exceeding one ng/ml for the extent of 24-weeks. Two patients from the control group (individuals that haven’t received implant) deceased.
Naltrexone implant approach to heroin addiction treatment and rehabilitation is out of harm’s way and considerably diminishes heroine consumption in inspired individuals.
Notwithstanding years of studying endorsing naltrexone’s usefulness in obstructing the “pleasant” effects of opiates, its medical practicality has not been completely evidenced. Lots of heroin-dependent individuals are hesitant or reject the naltrexone treatment. Also, many addicts start but fail to carry on the treatment.
Continued-release opioid antagonist method avoids the requirement for individuals to take the medicines on a daily basis. In clinical studies, each naltrexone implant reduced amount of heroin consumption effectively to the extent of 1 month. No randomized research of the efficacy of this device/formulation has been officially performed and documented, so the question of usefulness is still open.
Naltrexone implant “Subiaco”
The most efficient and safe anti-opioid implant on a market, “Subiaco” developed and manufactured by the experimental team of the Western Australian company GoMedical Industries capable of neutralizing the effect of opioids for 180 days. The physician who performs the implantation of “Subiaco” required receiving special training in at the GoMedical Industries training facility in Perth, Western Australia. This training ensures that the technique of the implantation of the “Subiaco” complemented the company’s criteria.
The incision for implantation is as small as a ½ inch and requires no stitches and can be closed using a water-resistant Band-Aid with the holographic seal. A follow-up visit usually scheduled in one week for the inspection of the incision and the seal removal.
“Opioid addicts are extremely uncertain,” declares Dr. George Woody, a professor of the department of psychiatry at the University of Pennsylvania in Philadelphia. “Just because they choose to stop consuming opioids one week doesn’t guarantee they will extend this enthusiasm 2-3 days later.”
The reasoning for sustained-release naltrexone implants is to deliver continued protection contrary to such uncertainty.
Addiction treatment using Naltrexone implant “Subiaco” in Philadelphia
Philadelphia Addiction Center is the leading alcohol and drug addiction clinic in the city and suburbs. Led by an internationally recognized specialist in addiction treatment Dr. Tsan, the professional team of this outpatient facility delivers the newest and most effective healing techniques, medicines, and devices.
Philadelphia Addiction Center is the only clinic in the area that implants “Subiaco” in patient’s body for long-lasting anti-opioids blocking effect. Dr. Tsan, medical director of the center, underwent special training to match GoMedical Industries standards of implantation and maintenance of the device.